PEG-MGF

PEG-MGF is a PEGylated variant of Mechano Growth Factor known for an extended half-life; the sparse community record centers on muscle growth and repair, drawn from exactly two captured user reports with mixed outcomes and low confidence. The only documented clinician protocol lists 200 mcg injected subcutaneously each day, while the community has not established a consistent dose, timing, or cycling pattern from its thin corpus. It holds no FDA-approved indication, meaning all human use is off-label or compounded and exists outside any regulatory framework governing safety or efficacy.

PEG-MGF

Research Evidence

Evidence shape

PEG-MGF sits at the lowest evidence tier because there is no human clinical data whatsoever in the registries or the mapped literature. The major databases show zero registered trials, zero completed studies, and zero mapped indications for this peptide. The absence is the only signal: no sponsor-backed program exists, no blinded results have ever been posted, and there is not even a scattered record of withdrawn, terminated, or unfinished studies to examine.

Depthhow much
0 registered trials
Breadthhow many areas
0 indications mapped
Qualityhow rigorous
No completed trials

Anecdotal efficacy

Side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Price

1
UK
5 mg
$43.11
$8.62/mg
2
--
5 mg
$60.00
$12/mg
3
US
5 mg
$62.00
$12.4/mg
4
US
5 mg
$63.00
$12.6/mg
5
--
5 mg
$69.00
$13.8/mg
6
US
2 mg
$29.95
$14.97/mg

price offers can be sorted by column

1-6 of 28

Dosing & Protocol

How PEG-MGF is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

Clinician practice
Doctor & published-protocol guidance · n = 1
Typical dose
200 µg
200 µg
200 µg
Frequency
daily
Timing
unspecified
Route
subQ
Cycle
unspecified

Clinician protocols dose 200 µg daily subQ (1 source).

1 source
Anecdotal
Community-reported real-world use · n = 2
Typical dose
No quantified dose captured for this tier.

No structured protocol details captured for this tier yet.

Anecdotal reports suggest use for muscle growth and repair, with 50% of 2 tracked reports being positive. No specific dose hints were extracted from community posts.

Peptide Deep Dive

Peptide Deep Dive is not projected for this peptide yet.

Peptide feedback

0 forum replies

Live community discussion for PEG-MGF, shown here in the site layout and continued on the TVR forum.

Add feedback

No peptide feedback yet

Start the peptide feedback thread on the TVR forum.